|
|
 | | | |
- close
- close
- close
- close
Medtox Scientific (MTOX) |
Benzinga
Aug 1
Comment
Laboratory Corporation of America® Holdings (NYSE: LH) today announced the completion of its acquisition of MEDTOX Scientific, Inc. (NASDAQ: MTOX), effective July 31, 2012.
At a special meeting held on July 31, 2012, MEDTOX's stockholders...
StreetInsider.com
Aug 1
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Laboratory+Corp+%28LH%29+Completes+MEDTOX+Scientific+Takeover/7620710.html for the full story.
Globe Newswire
Jul 20
Comment
ST. PAUL, Minn., July 20, 2012 (GLOBE NEWSWIRE) -- MEDTOX Scientific, Inc. (Nasdaq:MTOX) today announced that counsel for MEDTOX and other named defendants have today entered into a memorandum of understanding (MOU) with plaintiffs' counsel in
Globe Newswire
Jul 13
Comment
ST. PAUL, Minn., July 13, 2012 (GLOBE NEWSWIRE) -- MEDTOX Scientific, Inc. (Nasdaq:MTOX) today announced that the Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of
StreetInsider.com
Jul 12
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Medtox+Scientific%2C+Inc.+%28MTOX%29+Misses+Q2+EPS+by+7c/7575454.html for the full story.
Globe Newswire
Jul 12
Comment
ST. PAUL, Minn., July 12, 2012 (GLOBE NEWSWIRE) -- MEDTOX Scientific, Inc. (Nasdaq:MTOX) today announced results for the second quarter ended June 30, 2012. Highlights from the quarter compared to the prior-year period include: Total revenues
Globe Newswire
Jun 28
Comment
ST. PAUL, Minn., June 28, 2012 (GLOBE NEWSWIRE) -- MEDTOX Scientific, Inc. (Nasdaq:MTOX), announced in its definitive proxy statement on Schedule 14A that it has established a record date and a meeting date for a special meeting of its stockholders
StreetInsider.com
Jun 4
Comment
Cleveland Biolabs (Nasdaq: CBLI) 58.3% HIGHER; reported strong survival results for its randomized, blinded, placebo-controlled efficacy study of CBLB502 in 179 non-human primates (NHPs) conducted under Good Laboratory Practice (GLP) with elements...
Globe Newswire
Apr 12
Comment
ST. PAUL, Minn., April 12, 2012 (GLOBE NEWSWIRE) -- MEDTOX Scientific, Inc. (Nasdaq:MTOX) today announced results for the first quarter ended March 31, 2012. Highlights from the quarter compared to the prior-year period include: Total revenues
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
